FOI release

FOI2021/00012: Cell and gene therapy catapult spend

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2021/00012

Published 22 June 2021

Request

Request Received: 13 January 2021

Please provide answers to the following questions:

1. How much money has been spent by Innovate UK on cell and gene therapy catapult?

2. How much money has been spent on technology and digitisation? Alternatively, what have been the main areas of expenditure? What was the output of this spending? To clarify the question, how much funding was provided by Innovate UK to Cell and Gene Therapy annually since inception.

3. How much money was given to commercial technology partners of cell and gene therapy catapult? Who are the commercial partners, what was their function, and what technology or digital solution or services were provided and how did it help the sector?

4. How much money was spent with World Courier, DHL, ThermoFisher, Trakcel, Oxford Biomedica, and GSK? What was the purpose of the money and what was the result or outcome of such funding? What digital product and transformation was the result of such funding? To clarify the question, how much money has Cell and Gene Therapy Catapult provided to commercial partners annually, what was the money provided for and with which commercial partner, what products, solutions or outcomes was the funding for, and what specific identifiable outcomes, products or solutions were built or produced as a result of the funding provided to such commercial partners.

5. How many NHS hospitals, clinics or manufacturers in the UK or overseas are utilising innovations in technology produced by Trakcel or World Courier, and how much in funding was provided to these companies? To clarify the question, where, when or with which other entities, are any of the commercial partners' products or solutions being used

Response

Response Sent: 5 February 2021

Full details of this response are provided in the attached document.

Documents

• FOI_Response_Letter_FOI2021_00012_Redacted.pdf (192.0 KB)

This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.